BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

480 related articles for article (PubMed ID: 17467531)

  • 1. Pediatric keratoprosthesis.
    Aquavella JV; Gearinger MD; Akpek EK; McCormick GJ
    Ophthalmology; 2007 May; 114(5):989-94. PubMed ID: 17467531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Boston type I keratoprosthesis: improving outcomes and expanding indications.
    Aldave AJ; Kamal KM; Vo RC; Yu F
    Ophthalmology; 2009 Apr; 116(4):640-51. PubMed ID: 19243830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Boston type 1 keratoprosthesis: the university of california davis experience.
    Bradley JC; Hernandez EG; Schwab IR; Mannis MJ
    Cornea; 2009 Apr; 28(3):321-7. PubMed ID: 19387235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longer-term vision outcomes and complications with the Boston type 1 keratoprosthesis at the University of California, Davis.
    Greiner MA; Li JY; Mannis MJ
    Ophthalmology; 2011 Aug; 118(8):1543-50. PubMed ID: 21397948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Results from the multicenter Boston Type 1 Keratoprosthesis Study.
    Zerbe BL; Belin MW; Ciolino JB;
    Ophthalmology; 2006 Oct; 113(10):1779.e1-7. PubMed ID: 16872678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgical management of glaucoma in infants and children with Peters' anomaly: long-term structural and functional outcome.
    Yang LL; Lambert SR; Lynn MJ; Stulting RD
    Ophthalmology; 2004 Jan; 111(1):112-7. PubMed ID: 14711722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term visual prognosis in children after corneal transplant surgery for Peters anomaly type I.
    Zaidman GW; Flanagan JK; Furey CC
    Am J Ophthalmol; 2007 Jul; 144(1):104-108. PubMed ID: 17601429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of Boston keratoprosthesis in aniridia: a retrospective multicenter study.
    Akpek EK; Harissi-Dagher M; Petrarca R; Butrus SI; Pineda R; Aquavella JV; Dohlman CH
    Am J Ophthalmol; 2007 Aug; 144(2):227-231. PubMed ID: 17543875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AlphaCor keratoprosthesis: a novel approach to minimize the risks of long-term postoperative complications.
    Ngakeng V; Hauck MJ; Price MO; Price FW
    Cornea; 2008 Sep; 27(8):905-10. PubMed ID: 18724152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Keratoprosthesis: the Dohlman-Doane device.
    Aquavella JV; Qian Y; McCormick GJ; Palakuru JR
    Am J Ophthalmol; 2005 Dec; 140(6):1032-1038. PubMed ID: 16376647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Boston keratoprosthesis type II: the Massachusetts Eye and Ear Infirmary experience.
    Pujari S; Siddique SS; Dohlman CH; Chodosh J
    Cornea; 2011 Dec; 30(12):1298-303. PubMed ID: 21963861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Boston keratoprosthesis in Stevens-Johnson syndrome.
    Sayegh RR; Ang LP; Foster CS; Dohlman CH
    Am J Ophthalmol; 2008 Mar; 145(3):438-44. PubMed ID: 18207122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. International results with the Boston type I keratoprosthesis.
    Aldave AJ; Sangwan VS; Basu S; Basak SK; Hovakimyan A; Gevorgyan O; Kharashi SA; Jindan MA; Tandon R; Mascarenhas J; Malyugin B; Padilla MD; Maskati Q; Agarwala N; Hutauruk J; Sharma M; Yu F
    Ophthalmology; 2012 Aug; 119(8):1530-8. PubMed ID: 22512986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Boston keratoprosthesis in the management of corneal limbal stem cell deficiency.
    Sejpal K; Yu F; Aldave AJ
    Cornea; 2011 Nov; 30(11):1187-94. PubMed ID: 21885964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Refractive and corneal aberrometric changes after intracorneal ring implantation in corneas with pellucid marginal degeneration.
    PiƱero DP; Alio JL; Morbelli H; Uceda-Montanes A; El Kady B; Coskunseven E; Pascual I
    Ophthalmology; 2009 Sep; 116(9):1656-64. PubMed ID: 19643482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term results of corneal graft survival in infants and children with peters anomaly.
    Yang LL; Lambert SR; Lynn MJ; Stulting RD
    Ophthalmology; 1999 Apr; 106(4):833-48. PubMed ID: 10201611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Visual outcomes of Boston keratoprosthesis implantation as the primary penetrating corneal procedure.
    Kang JJ; de la Cruz J; Cortina MS
    Cornea; 2012 Dec; 31(12):1436-40. PubMed ID: 22367042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corneal replacement using a synthetic hydrogel cornea, AlphaCor: device, preliminary outcomes and complications.
    Hicks CR; Crawford GJ; Lou X; Tan DT; Snibson GR; Sutton G; Downie N; Werner L; Chirila TV; Constable IJ
    Eye (Lond); 2003 Apr; 17(3):385-92. PubMed ID: 12724702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AlphaCor keratoprosthesis: postoperative development of six patients.
    Holak SA; Holak HM; Bleckmann H
    Graefes Arch Clin Exp Ophthalmol; 2009 Apr; 247(4):535-9. PubMed ID: 18941767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-term visual outcomes of Boston type 1 keratoprosthesis implantation.
    Dunlap K; Chak G; Aquavella JV; Myrowitz E; Utine CA; Akpek E
    Ophthalmology; 2010 Apr; 117(4):687-92. PubMed ID: 20096462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.